ARCHIVES

ODAC Endorses Tamoxifen Trial, With Modification to Ensure Enrollment of Women At Higher Risk

This article is from The Cancer Letter archive.

Vol. 17 No. 31 | August 2, 1991

Download PDF Visit The Full Archive

Related Articles

NCI Advisory Group, Other Cancer Meetings

February 24, 1984

USPSTF Recommends Hepatitis C Screening For Baby Boomers

June 26, 2013

In Brief: Gene Therapy For ADA Deficiency Moves forward With Stem Cell Treatment In Caif. And At NIH

June 18, 1993

Review Guidelines For Comprehensive Centers Drafted, NCAB To Consider at December Meeting

November 24, 1989

In Brief: House, Senate Enact FY ’92 Budget Bills For NCI That Differ By $200 Million; Senate’s Is Higher

September 27, 1991

Prostate Cancer: NIH Pans To Ramp Up Prostate Cancer Research Funding

June 25, 1999